Results 91 to 100 of about 2,210 (155)
Contractile response to phenylephrine in intrapulmonary arteries from mice exposed to (A) normoxia (NX), (B) 10 days, (C) 21 days, and (D) 40 days of hypoxia (HX 10d, HX 21d and HX 40d, respectively), in the presence or absence of sepiapterin (10-4 M) or
Mathilde Dubois (264151) +12 more
core +1 more source
Background Phenylketonuria is an inherited condition characterised by neurotoxic accumulation of phenylalanine (Phe). APHENITY assessed the efficacy and safety of orally administered synthetic sepiapterin in children and adults with phenylketonuria ...
Margvelashvili, Lali +19 more
core +2 more sources
c.207C>G mutation in sepiapterin reductase causes autosomal dominant dopa-responsive dystonia
Objective:To elucidate the genetic cause of an Egyptian family with dopa-responsive dystonia (DRD), a childhood-onset dystonia, responding therapeutically to levodopa, which is caused by mutations in various genes.Methods:Rare variants in all coding ...
Ulrich Müller +11 more
core +1 more source
6-Acetyldihydrohomopterin and sepiapterin affect some GTP cyclohydrolase I's and not others [PDF]
The first enzyme in pteridine biosynthesis, GTP cyclohydrolase I, is a likely site for regulation of pteridine biosynthesis to occur. GTP cyclohydrolase I responds to hormonal treatment and is found altered in a variety of mice with genetically based ...
Jacobson, K. Bruce, Manos, Richard E.
core
Control of pteridine biosynthesis in the natural killer-like cell line YT.
The natural killer-like cell line YT constitutively expresses GTP-cyclohydrolase activity whereas 6-pyruvoyltetrahydropterin synthase and sepiapterin reductase are absent.
Yodoi, J. +3 more
core +1 more source
c.207C>G mutation in sepiapterin reductase causes autosomal dominant dopa-responsive dystonia [PDF]
Objective: To elucidate the genetic cause of an Egyptian family with dopa-responsive dystonia (DRD), a childhood-onset dystonia, responding therapeutically to levodopa, which is caused by mutations in various genes.
Kuhlenbäumer, G +11 more
core
AIM: AMPLIPHY is the first Phase 3 study comparing sepiapterin versus sapropterin in children and adults with phenylketonuria (PKU). METHODS: AMPLIPHY was an international, Phase 3, two-part, open-label study in participants with PKU aged ≥2 years ...
Peters, Heidi +22 more
core +1 more source
We report a 4-year-old girl with neurodevelopmental abnormalities who has maternal uniparental isodisomy of chromosome 2 leading to homozygosity for a likely pathogenic variant in SPR, and a variant of uncertain significance in ZNF142.
Janhawi Kelkar +3 more
doaj +1 more source
Udgivelsesdato: 2003-AprComplex-I inhibition and oxidative processes have been implicated in the loss of nigral dopamine neurones in Parkinson's disease and the toxicity of MPTP and its metabolite MPP+.
Gramsbergen, Jan Bert +11 more
core +1 more source
The biosynthesis of tetrahydrobiopterin from either dihydroneopterin triphosphate, sepiapterin, dihydrosepiapterin or dihydrobiopterin was investigated using extracts from human liver, dihydrofolate reductase and purified sepiapterin reductase from human
Heintel, Dorothee +5 more
core +1 more source

